s&o logo
  • News
  • Trade Ideas
  • Education
  • Community
Sign Up!
News

Cadence Design Systems stock is volatile right now: Here’s why

July 22, 2024 George Levine No comments yet

Cadence Design Systems (NASDAQ: CDNS) shares are volatile amid increased volatility following the company’s second-quarter 2024 financial results.

What Happened: Cadence reported better-than-expected adjusted EPS and sales results, but issued some soft guidance.

The company reported second-quarter adjusted EPS of $1.28, beating the consensus estimate of $1.22 and second-quarter sales of $1.061 billion, beating the $1.043 billion estimate.

The company issued third-quarter adjusted EPS guidance of $1.39 to $1.49, which is below the $1.60 estimate. The company also issued third-quarter revenue guidance of $1.165 billion to $1.195 billion, compared to the $1.19 billion estimate.

In terms of full year guidance, the company sees fiscal year 2024 adjusted EPS of $5.77 to $5.97, compared to the $5.93 estimate. For revenue, the company expects $4.6 billion to $4.66 billion, versus the $4.6 billion estimate.

Why The Stock Is Volatile: Cadence’s guidance is the likely cause for volatility. The company’s third-quarter adjusted EPS guidance is below what Wall Street is expecting and the company’s revenue guidance midpoint is below the analyst estimate.

Price Action: The stock was trading 1.13% lower to $283.83 at the time of writing. Cadence stock has a 52-week high of $328.99 and a 52-week low of $217.77.

  • Earnings

Post navigation

Previous
Next

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Education (15)
  • Featured (46)
  • News (85)
  • Trade Ideas (39)

Recent posts

  • FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
  • Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine
  • flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

Tags

BDRX CDT Conduit Conference Call CURR CURRENC Earnings Evergreen GH Research GHRS Grail GRAL HOLO IINN Inspira Technologies Interview IPWR JTAI KULR LCID Litigation LLY Lucid Motors M&A MedTech MicroCloud Movers MSTR My Size MYSZ News NLSP Novo Nordisk NVO Options Partnerships QNTM Quantum BioPharma Stock Market Stocks TAOP TELO Telomir Pharmaceuticals Traws Pharma TRWS

Continue reading

Featured, News, Trade Ideas

NLS Pharmaceutics and Kadimastem Move Closer to Merger Approval

January 31, 2025 Elisa Clay No comments yet

NLS Pharmaceutics (Nasdaq: NLSP) and Kadimastem (TASE: KDST) have reached a key milestone in their planned merger after Kadimastem’s shareholders approved the deal in a special general meeting. The merger aims to create a Nasdaq-listed biotechnology company with a strong portfolio of treatments for neurodegenerative diseases and diabetes. NLS is now preparing to hold its […]

Featured, News, Trade Ideas

Nukkleus Shares Surge 60% Amid Investor Optimism

January 17, 2025 Elisa Clay No comments yet

Nukkleus Inc. (NASDAQ: NUKK) saw its stock skyrocket by 60% during today’s trading session, marking a significant uptick in investor interest and market activity. The surge comes amid heightened speculation about the company’s growth prospects and potential strategic moves. While no major announcements were made by the company, the sharp increase in share price suggests […]

Featured, News, Trade Ideas

Inspira Technologies Ramps Up Production Readiness Amid hMPV Outbreak

January 10, 2025 Elisa Clay No comments yet

Inspira Technologies (Nasdaq: IINN), a leader in life-support technology innovation, has announced preparations for a potential production increase of its INSPIRA ART100 device. This proactive step comes in response to a recent outbreak of human metapneumovirus (hMPV) in China, which has brought renewed attention to the global need for advanced respiratory care solutions. The company […]

s&o logo

Our primary goal is to empower retail investors with helpful news, guides and trading ideas.

Helpful Links
  • News
  • Trade Ideas
  • Education
  • Community
Resources
  • Privacy Policy
  • Terms & Conditions
  • Contact
Get in touch
  • Email us!

© Copyright 2024, stocks&options. All Rights Reserved.